Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

BOM:524663 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 18, 2025	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Market Capitalization	1,032	958	1,213	1,965	251	332
Market Cap Growth	-5.98%	-21.03%	-38.24%	681.79%	-24.32%	-60.96%
Enterprise Value	-	1,678	1,902	2,321	533	149
Last Close Price	23.89	22.19	28.10	45.50	5.82	7.69
PS Ratio	13.48	2.15	1.55	2.30	0.38	0.40
PB Ratio	1.31	1.09	1.15	5.77	1.23	1.08
P/TBV Ratio	1.31	1.09	1.15	5.77	1.23	1.08
P/FCF Ratio	-	8.80	-	16.68	0.74	-
P/OCF Ratio	-	8.80	-	16.68	0.74	-
EV/Sales Ratio	-	3.76	2.43	2.72	0.80	0.18
EV/FCF Ratio	-	15.41	-	19.70	1.56	-
Debt / Equity Ratio	0.95	0.80	0.74	0.80	0.15	1.05
Debt / FCF Ratio	-	6.45	-	2.32	0.09	-
Asset Turnover	0.04	0.22	0.50	0.74	0.53	0.94
Inventory Turnover	1.40	2.08	2.41	2.50	1.70	8.75
Quick Ratio	0.19	0.20	0.09	0.07	0.20	0.86
Current Ratio	0.33	0.38	0.65	0.53	0.92	1.12
Return on Equity (ROE)	-21.00%	-17.19%	-12.56%	-66.45%	-39.93%	-16.99%
Return on Assets (ROA)	-6.28%	-5.00%	-2.04%	-11.41%	-5.21%	-6.56%
Return on Capital (ROIC)	-7.58%	-5.87%	-2.64%	-31.05%	-15.17%	-11.65%
Earnings Yield	-17.92%	-17.36%	-7.21%	-9.22%	-40.63%	-17.45%
FCF Yield	-	11.37%	-34.71%	5.99%	135.61%	-96.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.